(NASDAQ:CAPR) LOS ANGELES, Sept. 2, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ: CAPR ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated...
Related Questions
What is the estimated financial exposure and potential settlement amount for Capricor from this lawsuit?
How might the lawsuit affect CAPR's short-term stock volatility and trading volume?
What precedents exist for similar securities class actions, and how could they influence the outcome and timing?